J&J announced analyses from the MARIPOSA study involving the Royal Marsden Hospital in London, where Sanjay Popat serves as a medical oncologist.
1 report, 1 independent
Updated Sep 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
J&J announced analyses from the MARIPOSA study involving the Royal Marsden Hospital in London, where Sanjay Popat serves as a medical oncologist.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
-
The Royal Marsden NHS Foundation Trust
English cancer hospital
Nothing else this week.
Coverage
Newest first; wire copies grouped- PR NewswireRYBREVANT® (amivantamab-vmjw) plus LAZCLUZE® (lazertinib) prevents acquired resistance versus osimertinib in first-line EGFR-mutated non-small cell lung cancer RYBREVANT® combination extends survival